Matches in SemOpenAlex for { <https://semopenalex.org/work/W24762040> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W24762040 endingPage "8" @default.
- W24762040 startingPage "551" @default.
- W24762040 abstract "Although oral morphine is the gold standard in the front-line approach to moderate-severe cancer pain, transdermal opiates are largely used in clinical practice. Aims of our work were to review the evidences of literature supporting these different habits and to suggest an evidence-based criterion to guide clinical research and clinical practice. A systematic review of literature with meta-analysis of the safety data reported in randomized clinical trials comparing slow releasing oral morphine and transdermal opiates was performed using the random effect model. The quality of the evidences supporting the use of the different strategies and the strength of the recommendations was analyzed using the GRADE method. A significant advantage in favor of transdermal opiates was observed for constipation, urinary retention, need of laxative use and patient's preferences; a significant advantage in favor of slow releasing oral morphine was observed for diarrhea and sweating. The quality of the evidences supporting a front-line use of transdermal fentanyl was considered low, while those supporting the use of transdermal buprenorphine was considered very low. For the use oftransdermal fentanyl and for that oftransdermal buprenorphine a weak and a strong recommendation against their us as front-line treatment of moderate-severe cancer pain can be respectively obtained from the literature data. Transdermal opiates represent a safety and effective alternative to oral morphine against cancer pain, but they can not replace oral morphine as the gold standard first-line treatment of moderate-severe cancer pain." @default.
- W24762040 created "2016-06-24" @default.
- W24762040 creator A5006130493 @default.
- W24762040 creator A5013086481 @default.
- W24762040 creator A5054301443 @default.
- W24762040 creator A5082365619 @default.
- W24762040 creator A5091811562 @default.
- W24762040 creator A5091856899 @default.
- W24762040 date "2009-12-01" @default.
- W24762040 modified "2023-09-22" @default.
- W24762040 title "[Transdermal opiates in the treatment of moderate-severe cancer pain. Recommendations for clinical practice]." @default.
- W24762040 cites W1247968195 @default.
- W24762040 cites W1988116925 @default.
- W24762040 cites W2040995130 @default.
- W24762040 cites W2132469876 @default.
- W24762040 cites W2134236426 @default.
- W24762040 cites W2171040197 @default.
- W24762040 cites W2421628335 @default.
- W24762040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20178309" @default.
- W24762040 hasPublicationYear "2009" @default.
- W24762040 type Work @default.
- W24762040 sameAs 24762040 @default.
- W24762040 citedByCount "0" @default.
- W24762040 crossrefType "journal-article" @default.
- W24762040 hasAuthorship W24762040A5006130493 @default.
- W24762040 hasAuthorship W24762040A5013086481 @default.
- W24762040 hasAuthorship W24762040A5054301443 @default.
- W24762040 hasAuthorship W24762040A5082365619 @default.
- W24762040 hasAuthorship W24762040A5091811562 @default.
- W24762040 hasAuthorship W24762040A5091856899 @default.
- W24762040 hasConcept C121608353 @default.
- W24762040 hasConcept C126322002 @default.
- W24762040 hasConcept C141071460 @default.
- W24762040 hasConcept C170493617 @default.
- W24762040 hasConcept C205679159 @default.
- W24762040 hasConcept C2775842315 @default.
- W24762040 hasConcept C2777389121 @default.
- W24762040 hasConcept C2778904085 @default.
- W24762040 hasConcept C2778949969 @default.
- W24762040 hasConcept C2781063702 @default.
- W24762040 hasConcept C2781072394 @default.
- W24762040 hasConcept C2781112942 @default.
- W24762040 hasConcept C42219234 @default.
- W24762040 hasConcept C71924100 @default.
- W24762040 hasConcept C98274493 @default.
- W24762040 hasConceptScore W24762040C121608353 @default.
- W24762040 hasConceptScore W24762040C126322002 @default.
- W24762040 hasConceptScore W24762040C141071460 @default.
- W24762040 hasConceptScore W24762040C170493617 @default.
- W24762040 hasConceptScore W24762040C205679159 @default.
- W24762040 hasConceptScore W24762040C2775842315 @default.
- W24762040 hasConceptScore W24762040C2777389121 @default.
- W24762040 hasConceptScore W24762040C2778904085 @default.
- W24762040 hasConceptScore W24762040C2778949969 @default.
- W24762040 hasConceptScore W24762040C2781063702 @default.
- W24762040 hasConceptScore W24762040C2781072394 @default.
- W24762040 hasConceptScore W24762040C2781112942 @default.
- W24762040 hasConceptScore W24762040C42219234 @default.
- W24762040 hasConceptScore W24762040C71924100 @default.
- W24762040 hasConceptScore W24762040C98274493 @default.
- W24762040 hasIssue "12" @default.
- W24762040 hasLocation W247620401 @default.
- W24762040 hasOpenAccess W24762040 @default.
- W24762040 hasPrimaryLocation W247620401 @default.
- W24762040 hasVolume "100" @default.
- W24762040 isParatext "false" @default.
- W24762040 isRetracted "false" @default.
- W24762040 magId "24762040" @default.
- W24762040 workType "article" @default.